Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 May;108(5):425-31.
doi: 10.1007/s00347-010-2187-7.

[Drug therapy and radiotherapy in Graves' orbitopathy]

[Article in German]
F Beisse  1 , W A Lagrèze, M Schmucker
Affiliations

[Drug therapy and radiotherapy in Graves' orbitopathy]

[Article in German]
F Beisse et al. Ophthalmologe. 2011 May.

Abstract

Drug therapy and radiotherapy in Graves' orbitopathy (GO) aim mainly at the inherent soft tissue inflammation. A timely and sustained anti-inflammatory therapy not only alleviates the current symptoms but particularly intends to limit the degree of permanent alterations. It is indicated in active GO of moderate or higher severity. Pharmacologically, glucocorticoids and if appropriate other immunosuppressive agents, such as cyclosporine are given. Adverse effects can complicate the treatment. Retrobulbar irradiation is applied against diplopia due to eye muscle involvement during the active phase.

PubMed Disclaimer

Similar articles

  • Practical Guidelines Management of Graves Ophthalmopathy.
    Subekti I, Soewondo P, Soebardi S, Darmowidjojo B, Harbuwono DS, Purnamasari D, Tarigan TJE, Wisnu W, Tahapary DL, Kurniawan F, Sidik M, Nusanti S, Dewiputri S, Suharko H, Suardana GG, Suroyo I, Wulani V, Siswoyo AD, Gondhowiardjo S, Kodrat H. Subekti I, et al. Acta Med Indones. 2019 Oct;51(4):364-371. Acta Med Indones. 2019. PMID: 32041923
  • [Graves' Orbitopathy].
    Eckstein A, Esser J, Mattheis S, Berchner-Pfannschmidt U. Eckstein A, et al. Klin Monbl Augenheilkd. 2016 Dec;233(12):1385-1407. doi: 10.1055/s-0042-118040. Epub 2016 Nov 21. Klin Monbl Augenheilkd. 2016. PMID: 27871109 Review. German. No abstract available.
  • Optimal management of Graves orbitopathy: a multidisciplinary approach.
    Soeters MR, van Zeijl CJ, Boelen A, Kloos R, Saeed P, Vriesendorp TM, Mourits MP. Soeters MR, et al. Neth J Med. 2011 Jul-Aug;69(7):302-8. Neth J Med. 2011. PMID: 21934174 Review.
  • Natural history of graves' orbitopathy after treatment.
    Menconi F, Leo M, Sabini E, Mautone T, Nardi M, Sainato A, Sellari-Franceschini S, Vitti P, Marcocci C, Marinò M. Menconi F, et al. Endocrine. 2017 Aug;57(2):226-233. doi: 10.1007/s12020-016-1136-x. Epub 2016 Oct 5. Endocrine. 2017. PMID: 27709471
  • The evaluation and treatment of graves ophthalmopathy.
    Stan MN, Garrity JA, Bahn RS. Stan MN, et al. Med Clin North Am. 2012 Mar;96(2):311-28. doi: 10.1016/j.mcna.2012.01.014. Epub 2012 Feb 22. Med Clin North Am. 2012. PMID: 22443978 Free PMC article. Review.
See all similar articles

References

    1. J Clin Endocrinol Metab. 2005 Sep;90(9):5234-40 - PubMed
    1. Thyroid. 1997 Dec;7(6):885-9 - PubMed
    1. Eur J Endocrinol. 2007 Jan;156(1):33-40 - PubMed
    1. Eur J Clin Invest. 1986 Oct;16(5):415-22 - PubMed
    1. Clin Exp Immunol. 1996 Nov;106(2):197-202 - PubMed

Publication types

MeSH terms

LinkOut - more resources